Met Life Investment Management, LLC Heron Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 72,690 shares of HRTX stock, worth $125,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,690
Previous 72,055 0.88%
Holding current value
$125,753
Previous $143,000 22.38%
% of portfolio
0.0%
Previous 0.0%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$1.06 - $2.12 $673 - $1,346
635 Added 0.88%
72,690 $111,000
Q2 2024

Aug 13, 2024
BUY
$2.32 - $3.86 $74,110 - $123,303
31,944 Added 79.64%
72,055 $252,000
Q1 2024

May 14, 2024
BUY
$1.71 - $3.06 $68,589 - $122,739
40,111 New
40,111 $111,000
Q2 2023

Apr 29, 2024
BUY
$1.11 - $2.88 $59,456 - $154,264
53,564 New
53,564 $62,000
Q1 2023

May 09, 2024
BUY
$1.51 - $3.25 $80,881 - $174,083
53,564 New
53,564 $80.9 Million
Q1 2022

May 10, 2024
BUY
$4.63 - $9.94 $248,001 - $532,426
53,564 New
53,564 $306,000
Q1 2022

Mar 22, 2023
BUY
$4.63 - $9.94 $96,262 - $206,662
20,791 Added 63.44%
53,564 $306,000
Q1 2022

May 12, 2022
BUY
$4.63 - $9.94 $96,262 - $206,662
20,791 Added 63.44%
53,564 $306,000
Q4 2021

Jun 21, 2023
SELL
$8.35 - $12.6 $173,604 - $261,966
-20,791 Reduced 38.82%
32,773 $299,000
Q3 2021

Jun 21, 2023
SELL
$10.13 - $15.0 $210,612 - $311,865
-20,791 Reduced 38.82%
32,773 $350,000
Q2 2021

Jun 21, 2023
SELL
$13.27 - $18.48 $275,896 - $384,217
-20,791 Reduced 38.82%
32,773 $508,000
Q1 2021

May 17, 2024
SELL
$14.49 - $20.72 $106,327 - $152,043
-7,338 Reduced 18.29%
32,773 $531,000
Q1 2021

Jun 26, 2023
SELL
$14.49 - $20.72 $301,261 - $430,789
-20,791 Reduced 38.82%
32,773 $531 Million
Q1 2021

Mar 22, 2023
SELL
$14.49 - $20.72 $91,301 - $130,556
-6,301 Reduced 16.13%
32,773 $531,000
Q1 2021

May 14, 2021
SELL
$14.49 - $20.72 $91,301 - $130,556
-6,301 Reduced 16.13%
32,773 $531,000
Q4 2020

Jun 22, 2023
SELL
$14.61 - $22.14 $211,698 - $320,808
-14,490 Reduced 27.05%
39,074 $827,000
Q3 2020

Jun 26, 2023
SELL
$13.67 - $17.77 $198,078 - $257,487
-14,490 Reduced 27.05%
39,074 $579,000
Q2 2020

May 24, 2024
SELL
$10.89 - $21.47 $11,292 - $22,264
-1,037 Reduced 2.59%
39,074 $575 Million
Q2 2020

Jun 26, 2023
SELL
$10.89 - $21.47 $157,796 - $311,100
-14,490 Reduced 27.05%
39,074 $574,000
Q2 2020

Mar 22, 2023
BUY
$10.89 - $21.47 $27,551 - $54,319
2,530 Added 6.92%
39,074 $574,000
Q2 2020

Aug 14, 2020
BUY
$10.89 - $21.47 $27,551 - $54,319
2,530 Added 6.92%
39,074 $575,000
Q1 2020

Jul 12, 2023
SELL
$10.23 - $24.56 $174,114 - $418,011
-17,020 Reduced 31.78%
36,544 $429,000
Q4 2019

Jul 12, 2023
SELL
$17.42 - $26.61 $296,488 - $452,902
-17,020 Reduced 31.78%
36,544 $858,000
Q4 2019

Mar 22, 2023
BUY
$17.42 - $26.61 $47,086 - $71,926
2,703 Added 7.99%
36,544 $858,000
Q4 2019

Feb 14, 2020
BUY
$17.42 - $26.61 $47,086 - $71,926
2,703 Added 7.99%
36,544 $859,000
Q3 2019

Jul 12, 2023
SELL
$16.36 - $21.39 $322,668 - $421,874
-19,723 Reduced 36.82%
33,841 $626,000
Q3 2019

Mar 22, 2023
BUY
$16.36 - $21.39 $73,211 - $95,720
4,475 Added 15.24%
33,841 $626,000
Q3 2019

Nov 14, 2019
BUY
$16.36 - $21.39 $73,211 - $95,720
4,475 Added 15.24%
33,841 $626,000
Q2 2019

Jul 12, 2023
SELL
$16.93 - $26.22 $333,910 - $517,137
-19,723 Reduced 36.82%
33,841 $629,000
Q1 2019

Jul 13, 2023
SELL
$23.15 - $28.34 $560,183 - $685,771
-24,198 Reduced 45.18%
29,366 $717,000
Q4 2018

Jul 13, 2023
SELL
$22.03 - $32.01 $533,081 - $774,577
-24,198 Reduced 45.18%
29,366 $761,000
Q4 2018

Mar 22, 2023
SELL
$22.03 - $32.01 $382,220 - $555,373
-17,350 Reduced 37.14%
29,366 $761,000
Q4 2018

Feb 14, 2019
SELL
$22.03 - $32.01 $382,220 - $555,373
-17,350 Reduced 37.14%
29,366 $762,000
Q3 2018

Jul 13, 2023
SELL
$30.0 - $40.85 $725,940 - $988,488
-24,198 Reduced 45.18%
29,366 $929,000
Q3 2018

Mar 22, 2023
SELL
$30.0 - $40.85 $205,440 - $279,740
-6,848 Reduced 12.78%
46,716 $1.48 Million
Q3 2018

Nov 14, 2018
BUY
$30.0 - $40.85 $520,500 - $708,747
17,350 Added 59.08%
46,716 $1.48 Million
Q2 2018

Aug 15, 2018
BUY
$26.4 - $42.0 $116,001 - $184,548
4,394 Added 17.6%
29,366 $1.14 Million
Q1 2018

May 15, 2018
BUY
$18.43 - $28.8 $53,926 - $84,268
2,926 Added 13.27%
24,972 $689,000
Q4 2017

Feb 15, 2018
BUY
$14.8 - $18.85 $326,280 - $415,567
22,046
22,046 $399,000

Others Institutions Holding HRTX

# of Institutions
173
Shares Held
114M
Call Options Held
2M
Put Options Held
32.4K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $205M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email